Starting May 14th, 2021, the data in LocatorPlus.gov will be frozen in preparation for the migration to the new Primo VE-powered LocatorPlus Catalog which goes live June 8th, 2021. See the Technical Bulletin article for more information. LocatorPlus.gov will remain available until August 31st, 2021.

Start Over
Detailed View
SearchTitlesLibrary InformationOther DatabasesHelpHome


Collections of the National Library of Medicine
Search Request: Simple Search = 101706984
Search Results: Displaying 1 of 1 records

Summary ViewDetailed ViewTable of ContentsMARC ViewMore Like This

The changing epidemiology of HPV and cervical cancer : from etiology, to...

Title: The changing epidemiology of HPV and cervical cancer : from etiology, to validation of prevention methods, to dissemination / Mark Schiffman.
Author(s)/Relationship(s): Schiffman, Mark, 1954- speaker.
Publisher: [Bethesda, Md.] : [National Institutes of Health], [2017]
Related Names: National Institutes of Health (U.S.), sponsoring body.
Series: NIH Wednesday afternoon lecture
Description: 1 online resource (1 streaming video file (53 min.)) : color, sound
Content Type: two-dimensional moving image
Media Type: computer
Carrier Type: online resource
Language: eng
Electronic Links: https://videocast.nih.gov/launch.asp?23254
MeSH Subjects: Uterine Cervical Neoplasms --epidemiology
Uterine Cervical Neoplasms --genetics
Epidemiologic Studies
Papillomaviridae --pathogenicity
Lecture
Webcast
Summary: (CIT): NIH Director’s Wednesday Afternoon Lecture Series Over three decades of studies moving from etiology to preventive methods research to guidelines development, Dr. Schiffman has learned some broad lessons about the strengths and weaknesses of epidemiology that he will describe. He joined the Clinical Genetics Branch in October 2009 to study intensively why HPV is such a powerful carcinogenic exposure, akin to an acquired genetic trait with high penetrance for a cancer phenotype. The main studies in which Dr. Schiffman played a major role in the past 5 years, listed chronologically, include: The Portland Kaiser Cohort; the Taiwan Cohort Study; the Guanacaste Natural History Study; the ASCUS-LSIL Triage Study (ALTS); the Study to Understand Cervical Cancer Early Endpoints and Determinants (SUCCEED/Biopsy); the Costa Rica Vaccine Trial (CVT); the Persistence and Progression (PaP) Study; and Nigeria Project Itoju. These studies overall have related HPV status to outcome for more than 100,000 women.
Notes: Closed-captioned.
NLM Unique ID: 101706984
Other ID Numbers: (DNLM)CIT:23254
(OCoLC)993648657

SFX



Options for Print, Save or E-mail
Select Download Format:
E-mail Full record(s) to:


SearchTitlesLibrary InformationOther DatabasesHelpHome

Copyright, Privacy, Accessibility
U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
National Institutes of Health, Health & Human Services
Contact NLM